|
CTNNA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.499600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.330200E-02 |
| Normal-vs-Stage2 |
5.382800E-01 |
| Normal-vs-Stage3 |
2.381600E-01 |
| Normal-vs-Stage4 |
7.092400E-01 |
| Stage1-vs-Stage2 |
5.048200E-01 |
| Stage1-vs-Stage3 |
8.580200E-01 |
| Stage1-vs-Stage4 |
2.378200E-01 |
| Stage2-vs-Stage3 |
6.469800E-01 |
| Stage2-vs-Stage4 |
8.181600E-01 |
| Stage3-vs-Stage4 |
4.581200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.931900E-02 |
| Normal-vs-AfricanAmerican |
4.317800E-02 |
| Normal-vs-Asian |
6.787400E-01 |
| Caucasian-vs-AfricanAmerican |
7.922200E-01 |
| Caucasian-vs-Asian |
9.683000E-01 |
| AfricanAmerican-vs-Asian |
8.877800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.036000E-02 |
| Normal-vs-Female |
6.478000E-03 |
| Male-vs-Female |
1.244190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.821800E-01 |
| Normal-vs-Extreme_Weight |
1.236440E-01 |
| Normal-vs-Obese |
1.077570E-02 |
| Normal-vs-Extreme_Obese |
6.749000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.381800E-01 |
| Normal_Weight-vs-Obese |
8.704400E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.487000E-01 |
| Extreme_Weight-vs-Obese |
4.533000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.278600E-01 |
| Obese-vs-Extreme_Obese |
1.156810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.987600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.825730E-04 |
| Normal-vs-Age(61-80Yrs) |
4.854400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.281600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.992200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.732000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.869000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.795400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.392200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.435800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.998600E-04 |
| Normal-VS-Type2 PRCC |
6.658800E-01 |
| Normal-VS-KIRP CIMP |
5.113400E-01 |
| Normal-VS-Unclassified PRCC |
7.253700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.738000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.165160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.533600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.980000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.423850E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.890400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.921800E-01 |
| Normal-vs-N1 |
4.695200E-01 |
| Normal-vs-N2 |
7.826200E-01 |
| N0-vs-N1 |
8.731800E-01 |
| N0-vs-N2 |
7.642200E-01 |
| N1-vs-N2 |
6.358400E-01 |
|
|
